.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
QuintilesIMS
Daiichi Sankyo
Queensland Health
Healthtrust
Federal Trade Commission
Harvard Business School
Accenture
Fuji

Generated: December 12, 2017

DrugPatentWatch Database Preview

METADATE CD Drug Profile

« Back to Dashboard

Which patents cover Metadate Cd, and when can generic versions of Metadate Cd launch?

Metadate Cd is a drug marketed by Ucb Inc and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.

This drug has sixteen patent family members in eleven countries.

The generic ingredient in METADATE CD is methylphenidate hydrochloride. There are thirty-one drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Ucb IncMETADATE CDmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021259-003May 27, 2003AB2RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Ucb IncMETADATE CDmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021259-004Feb 19, 2006AB2RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Ucb IncMETADATE CDmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021259-001Apr 3, 2001AB2RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Ucb IncMETADATE CDmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021259-002Jun 19, 2003AB2RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Ucb IncMETADATE CDmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021259-006Feb 19, 2006AB2RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Ucb IncMETADATE CDmethylphenidate hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL021259-005Feb 19, 2006AB2RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for METADATE CD

Drugname Dosage Strength RLD Submissiondate
metformin hydrochlorideExtended-release Capsules40 mgMetadate CD3/15/2007
metformin hydrochlorideExtended-release Capsules10 mg, 20 mg and 30 mgMetadate CD5/13/2005

International Patent Family for Tradename: METADATE CD

Country Document Number Estimated Expiration
European Patent Office1328251► Subscribe
Portugal2103307► Subscribe
Australia9701101► Subscribe
Canada2426883► Subscribe
European Patent Office2286815► Subscribe
Poland361673► Subscribe
World Intellectual Property Organization (WIPO)0234234► Subscribe
Hungary0303695► Subscribe
Australia2001297011► Subscribe
Poland203828► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Fuji
Farmers Insurance
Fish and Richardson
Citi
Accenture
US Department of Justice
Queensland Health
AstraZeneca
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot